Chemo's hidden toll: new study tracks hair, skin, and nail changes in breast cancer patients

NCT ID NCT02530177

Ongoing Knowledge-focused Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 546 women with non-metastatic breast cancer to see how chemotherapy or endocrine therapy affects their hair, skin, and nails. Researchers will use clinical exams, photos, and questionnaires to track changes and identify who is most at risk. The goal is to better understand these side effects and improve how doctors prevent and treat them.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict and manage chemotherapy-related hair, skin, and nail side effects, improving quality of life for breast cancer patients.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia breast cancer breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON METASTATIC BREAST CANCER

Contacts and locations

Locations

Memorial Sloan Kettering Cancer Center

New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.